Luo M - Search Results

1

Carrier-Free Nanoplatform via Evoking Pyroptosis and Immune Response against Breast Cancer.

Li L, Tian H, Zhang Z, Ding N, He K, Lu S, Liu R, Wu P, Wang Y, He B, Luo M, Peng P, Yang M, Nice EC, Huang C, Xie N, Wang D, Gao W. Li L, et al. Among authors: luo m. ACS Appl Mater Interfaces. 2023 Jan 11;15(1):452-468. doi: 10.1021/acsami.2c17579. Epub 2022 Dec 20. ACS Appl Mater Interfaces. 2023. PMID: 36538368

2

Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identification.

Fu S, Liu X, Luo M, Xie K, Nice EC, Zhang H, Huang C. Fu S, et al. Among authors: luo m. Expert Rev Proteomics. 2017 Apr;14(4):351-362. doi: 10.1080/14789450.2017.1299006. Epub 2017 Mar 6. Expert Rev Proteomics. 2017. PMID: 28276747 Review.

3

Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma.

Chen Y, Chen HN, Wang K, Zhang L, Huang Z, Liu J, Zhang Z, Luo M, Lei Y, Peng Y, Zhou ZG, Wei Y, Huang C. Chen Y, et al. Among authors: luo m. J Hepatol. 2019 Jan;70(1):66-77. doi: 10.1016/j.jhep.2018.09.022. Epub 2018 Oct 1. J Hepatol. 2019. PMID: 30287340

4

ZNF37A promotes tumor metastasis through transcriptional control of THSD4/TGF-β axis in colorectal cancer.

Liu J, Huang Z, Chen HN, Qin S, Chen Y, Jiang J, Zhang Z, Luo M, Ye Q, Xie N, Zhou ZG, Wei Y, Xie K, Huang C. Liu J, et al. Among authors: luo m. Oncogene. 2021 May;40(19):3394-3407. doi: 10.1038/s41388-021-01713-9. Epub 2021 Apr 19. Oncogene. 2021. PMID: 33875786

5

Epigenetic Regulation of Epithelial to Mesenchymal Transition in the Cancer Metastatic Cascade: Implications for Cancer Therapy.

Liu QL, Luo M, Huang C, Chen HN, Zhou ZG. Liu QL, et al. Among authors: luo m. Front Oncol. 2021 Apr 29;11:657546. doi: 10.3389/fonc.2021.657546. eCollection 2021. Front Oncol. 2021. PMID: 33996581 Free PMC article. Review.

6

Drug resistance in colorectal cancer: An epigenetic overview.

Luo M, Yang X, Chen HN, Nice EC, Huang C. Luo M, et al. Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188623. doi: 10.1016/j.bbcan.2021.188623. Epub 2021 Sep 1. Biochim Biophys Acta Rev Cancer. 2021. PMID: 34481016 Review.

7

Redox-sensitive cyclophilin A elicits chemoresistance through realigning cellular oxidative status in colorectal cancer.

Peng L, Jiang J, Chen HN, Zhou L, Huang Z, Qin S, Jin P, Luo M, Li B, Shi J, Xie N, Deng LW, Liou YC, Nice EC, Huang C, Wei Y. Peng L, et al. Among authors: luo m. Cell Rep. 2021 Nov 30;37(9):110069. doi: 10.1016/j.celrep.2021.110069. Cell Rep. 2021. PMID: 34852234 Free article.

8

Redox signaling at the crossroads of human health and disease.

Zuo J, Zhang Z, Luo M, Zhou L, Nice EC, Zhang W, Wang C, Huang C. Zuo J, et al. Among authors: luo m. MedComm (2020). 2022 Mar 31;3(2):e127. doi: 10.1002/mco2.127. eCollection 2022 Jun. MedComm (2020). 2022. PMID: 35386842 Free PMC article. Review.

9

Antioxidant Therapy in Cancer: Rationale and Progress.

Luo M, Zhou L, Huang Z, Li B, Nice EC, Xu J, Huang C. Luo M, et al. Antioxidants (Basel). 2022 Jun 8;11(6):1128. doi: 10.3390/antiox11061128. Antioxidants (Basel). 2022. PMID: 35740025 Free PMC article. Review.

10

Repurposing econazole as a pharmacological autophagy inhibitor to treat pancreatic ductal adenocarcinoma.

Weng N, Qin S, Liu J, Huang X, Jiang J, Zhou L, Zhang Z, Xie N, Wang K, Jin P, Luo M, Peng L, Nice EC, Goel A, Han S, Huang C, Zhu Q. Weng N, et al. Among authors: luo m. Acta Pharm Sin B. 2022 Jul;12(7):3085-3102. doi: 10.1016/j.apsb.2022.01.018. Epub 2022 Feb 4. Acta Pharm Sin B. 2022. PMID: 35865101 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,364 results

Search Page